Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aytu BioPharma, Inc. - Common Stock (NQ:AYTU)

2.380 +0.050 (+2.15%)
Streaming Delayed Price Updated: 12:55 PM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 471,954
Open 2.310
Bid (Size) 2.340 (2)
Ask (Size) 2.390 (3)
Prev. Close 2.330
Today's Range 2.310 - 2.580
52wk Range 0.9500 - 2.850
Shares Outstanding 5,567,490
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
This Starbucks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga

Performance

YTD
+39.8%
+39.8%
1 Month
+8.2%
+8.2%
3 Month
+20.2%
+20.2%
6 Month
+93.5%
+93.5%
1 Year
-7.4%
-7.4%

More News

Read More
Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)
Via ACCESS Newswire
Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)
Via ACCESS Newswire
Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock
Via ACCESS Newswire
Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results
Via ACCESS Newswire
Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan
Via ACCESS Newswire
Which stocks are moving on Friday?
Via Chartmill
Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States
Via ACCESS Newswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
These stocks have an unusual volume in today's session
Via Chartmill
Top movers in Friday's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Via Chartmill
These stocks are gapping in today's session
Via Chartmill
Top movers in Thursday's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Boot Barn Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results
Via ACCESS Newswire
Aytu BioPharma to Report Fiscal 2025 Third Quarter Operational and Financial Results on May 14, 2025
Via ACCESS Newswire
Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
Via ACCESS Newswire
Earnings Scheduled For May 14, 2025
Via Benzinga

Frequently Asked Questions

Is Aytu BioPharma, Inc. - Common Stock publicly traded?
Yes, Aytu BioPharma, Inc. - Common Stock is publicly traded.
What exchange does Aytu BioPharma, Inc. - Common Stock trade on?
Aytu BioPharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aytu BioPharma, Inc. - Common Stock?
The ticker symbol for Aytu BioPharma, Inc. - Common Stock is AYTU on the Nasdaq Stock Market
What is the current price of Aytu BioPharma, Inc. - Common Stock?
The current price of Aytu BioPharma, Inc. - Common Stock is 2.380
When was Aytu BioPharma, Inc. - Common Stock last traded?
The last trade of Aytu BioPharma, Inc. - Common Stock was at 09/16/25 12:55 PM ET
What is the market capitalization of Aytu BioPharma, Inc. - Common Stock?
The market capitalization of Aytu BioPharma, Inc. - Common Stock is 13.25M
How many shares of Aytu BioPharma, Inc. - Common Stock are outstanding?
Aytu BioPharma, Inc. - Common Stock has 13M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.